-
WCLC 2024 | Global Survey: Barriers to Optimal Biomarker Testing for Lung Cancer
The 2024 World Conference on Lung Cancer (WCLC) will be held in San Diego, USA, from September 7-10. Dr. Matthew Smeltzer, Associate Professor , Division of Epidemiology, Biostatistics, and Environmental Health at the University of Memphis, Tennessee, will present the analysis of the “2024 International Association for the Study of Lung Cancer (IASLC) Global Survey…
-
Annual Review | Academician Xu Zhang: Chinese Doctors Leading a New Revolution in Urological Surgery Innovation
Time rewards those who strive, and success comes to those who persevere. As 2023 draws to a close, the year has left behind many noteworthy achievements in China’s field of urology, especially in the areas of prostate cancer surgery and drug treatments. On this occasion, Urology Frontier interviewed Xu Zhang, Academician of the Chinese PLA…
-
Academician Xu Zhang: “Nivolumab” Assists in UC Treatment, Filling the Gap in First-Line mUC Therapy, Leading the Era of Immunotherapy for UC
At the 2023 ESMO Congress, the field of urothelial carcinoma (UC) witnessed a major breakthrough. The global multicenter Phase III CheckMate-901 study showed that in the first-line treatment of unresectable or metastatic urothelial carcinoma (mUC), nivolumab combined with cisplatin-based chemotherapy achieved dual positive results in the co-primary endpoints of overall survival (OS) and progression-free survival…
-
Academician Xu Zhang’s Team Showcases the Expertise of Chinese Urology at the SRS World Robotic Surgery Society
In the winter along the Neckar River, Heidelberg’s old town was adorned in snow, providing a fitting backdrop for an academic atmosphere rich in culture and freedom. The “Semi-Live 2024” International Urology Conference and the CGAU Academic Annual Meeting between China and Germany were successfully held from January 18 to 20 in Heidelberg, a hub…
-
Delicate and Thin Fibrous Septa Indicate a Regression Tendency in MASH Patients with Advanced Fibrosis
Previous studies have demonstrated that liver fibrosis can be reversible if the underlying cause is controlled. Wanless and colleagues described the pathological changes associated with cirrhosis regression in chronic hepatitis…
-
JOH | New Machine Learning Model Accurately Predicts Risk of Liver-Related Complications After Chronic Hepatitis B Cure
The development and application of the PLAN-B-CURE model mark an important step forward in managing chronic HBV. The model not only improves prediction accuracy but also provides a scientific foundation…
-
PANoptosis-Related Gene Signature Predicts Prognosis and Immune Status in Biliary Tract Cancer Patients
Recent research has highlighted the crucial role of the tumor microenvironment in BTC progression and invasiveness. The primary goal of cancer therapy is to disrupt tumor cells, and a key…
-
CID’s Most-Read Article: “Miracle Drug” Metformin Significantly Reduces Viral Load in Outpatient COVID-19 Patients!
Metformin has demonstrated antiviral activity against RNA viruses, including SARS-CoV-2. The drug’s mechanism appears to involve targeting the host’s mTOR pathway to inhibit protein translation. The COVID-OUT trial was a…
Connecting Medical Expertise through Media